5-alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial

Teemu J Murtola; Elina K Karppa; Taari Kimmo; K Taari; Kirsi Talala; Teuvo L Tammela; Anssi Auvinen

doi:10.1002/ijc.30017

5-alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial

Teemu J Murtola, Elina K Karppa, Taari Kimmo, K Taari, Kirsi Talala, Teuvo L Tammela, Anssi Auvinen

Research output: Contribution to journal › Article › Scientific › peer-review

21 Citations (Scopus)

Original language	English
Pages (from-to)	2820-2828
Journal	International Journal of Cancer
Volume	138
Issue number	12
DOIs	https://doi.org/10.1002/ijc.30017
Publication status	Published - 2016
Publication type	A1 Journal article-refereed

Keywords

5-alpha reductase inhibitors
Adrenergic alpha-Blockers
Prostate cancer
Survival

Publication forum classification

Publication forum level 2

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ijc.30017

Cite this

@article{e01f371d88484564a6b5aa3919823c8e,

title = "5-alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial",

keywords = "5-alpha reductase inhibitors, Adrenergic alpha-Blockers, Prostate cancer, Survival, 5-alpha reductase inhibitors, Adrenergic alpha-Blockers, Prostate cancer, Survival",

author = "Murtola, {Teemu J} and Karppa, {Elina K} and Taari Kimmo and K Taari and Kirsi Talala and Tammela, {Teuvo L} and Anssi Auvinen",

year = "2016",

doi = "10.1002/ijc.30017",

language = "English",

volume = "138",

pages = "2820--2828",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "Wiley",

number = "12",

}

TY - JOUR

T1 - 5-alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial

AU - Murtola, Teemu J

AU - Karppa, Elina K

AU - Kimmo, Taari

AU - Taari, K

AU - Talala, Kirsi

AU - Tammela, Teuvo L

AU - Auvinen, Anssi

PY - 2016

Y1 - 2016

KW - 5-alpha reductase inhibitors

KW - Adrenergic alpha-Blockers

KW - Prostate cancer

KW - Survival

KW - 5-alpha reductase inhibitors

KW - Adrenergic alpha-Blockers

KW - Prostate cancer

KW - Survival

U2 - 10.1002/ijc.30017

DO - 10.1002/ijc.30017

M3 - Article

SN - 0020-7136

VL - 138

SP - 2820

EP - 2828

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 12

ER -